BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
April 1, 2009
View Archived Issues
Intercell Gets Stock Boost as FDA Approves Ixiaro
Shares in Intercell AG received a significant boost Tuesday on news that the FDA approved its Japanese Encephalitis Virus (JEV) vaccine Ixiaro late Monday. (BioWorld International)
Read More
BioVex Raises $40M to Fund Melanoma Vaccine Study
Read More
More Breast Cancer Genes to Boost Genetic Screening
Read More
EU Animal Directive Draws Ire from UK Researchers
Read More
Survey Points to Trouble Raising Funds in the UK
Read More
TcLand, Genedata Collaborate on Autoimmune Biomarkers
Read More
Newron Moves Ralfinamide into Pivotal Pain Trials
Read More
Other News To Note
Read More